Department of Cell Biology, Biomedical Research Foundation, Academy of Athens, 115 27 Athens, Greece.
Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20816-21. doi: 10.1073/pnas.1005888107. Epub 2010 Nov 12.
Scavenger receptor class B type I (SR-BI) is a high-density lipoprotein receptor that regulates cholesterol efflux from the peripheral tissues to the liver. SR-BI has been identified on astrocytes and vascular smooth muscle cells in Alzheimer's disease brain and has been shown to mediate adhesion of microglia to fibrillar amyloid-β (Aβ). Here we report that SR-BI mediates perivascular macrophage response and regulates Aβ-related pathology and cerebral amyloid angiopathy in an Alzheimer's mouse model. Reduction or deletion of SR-BI gene in heterozygous or homozygous deficient mice (SR-BI(+/-), (-/-)) resulted in a significant increase in perivascular macrophages in the brain. SR-BI deletion had no effect on apolipoprotein E or apolipoprotein AI levels in the mouse brain. Our analysis revealed increased levels of SR-BI expression in the brains of human amyloid precursor protein (Swedish, Indiana) transgenic mice (J20 line). To evaluate the role of SR-BI in Alzheimer's disease pathogenesis, we inactivated one SR-BI allele in J20 transgenic mice. SR-BI reduction in J20/SR-BI(+/-) mice enhanced fibrillar amyloid deposition and cerebral amyloid angiopathy and also exacerbated learning and memory deficits compared with J20 littermates. Immunohistochemical analysis revealed localization of SR-BI on perivascular macrophages in tight association with Aβ deposits. Our data suggest that SR-BI reduction impairs the response of perivascular macrophages to Aβ and enhances the Aβ-related phenotype and cerebral amyloid angiopathy in J20 mice. These results reveal that SR-BI, a scavenger receptor primarily involved in high-density lipoprotein cholesterol transport, plays an essential role in Alzheimer's disease and cerebral amyloid angiopathy.
清道夫受体 B 类 I 型(SR-BI)是一种高密度脂蛋白受体,可调节外周组织中的胆固醇流出到肝脏。在阿尔茨海默病大脑中的星形胶质细胞和血管平滑肌细胞上已鉴定出 SR-BI,并已表明它介导小胶质细胞与纤维状淀粉样蛋白-β(Aβ)的黏附。在这里,我们报告 SR-BI 介导周细胞巨噬细胞反应,并调节阿尔茨海默病小鼠模型中的 Aβ 相关病理学和脑淀粉样血管病。杂合或纯合缺失 SR-BI 基因的小鼠(SR-BI(+/-),(-/-))导致大脑中的周细胞巨噬细胞数量显著增加。SR-BI 缺失对载脂蛋白 E 或载脂蛋白 AI 水平在小鼠脑中没有影响。我们的分析显示,人类淀粉样前体蛋白(瑞典,印第安纳)转基因小鼠(J20 系)脑中的 SR-BI 表达水平增加。为了评估 SR-BI 在阿尔茨海默病发病机制中的作用,我们在 J20 转基因小鼠中失活一个 SR-BI 等位基因。与 J20 同窝仔相比,J20/SR-BI(+/-) 小鼠中 SR-BI 的减少增强了纤维状淀粉样蛋白沉积和脑淀粉样血管病,并加剧了学习和记忆缺陷。免疫组织化学分析显示 SR-BI 定位于与 Aβ 沉积物紧密相关的周细胞巨噬细胞上。我们的数据表明,SR-BI 的减少损害了周细胞巨噬细胞对 Aβ 的反应,并增强了 J20 小鼠的 Aβ 相关表型和脑淀粉样血管病。这些结果表明,主要参与高密度脂蛋白胆固醇转运的清道夫受体 SR-BI 在阿尔茨海默病和脑淀粉样血管病中发挥着重要作用。